SCHEMBL4757398

SCHEMBL4757398

CS(=O)(=O)Nc1csc(NC(=O)c2cc(Br)ccc2O)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 1/20 0.51
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
GAA P10253 4/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
RCE1 Q9Y256 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
TMPRSS4 Q9NRS4 1/20 0.41
MAPT P10636 2/20 0.41
PLAU P00749 2/20 0.40
F2 P00734 1/20 0.40
F10 P00742 1/20 0.40
PLAT P00750 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757394 0.83 NPC1 (0.64) NPC1RAB9AGAAKDM4EHPGD
SCHEMBL330537 0.78 NPC1 (0.70) SORT1NPC1RAB9AGAAKDM4E
SCHEMBL4757484 0.78 SORT1 (0.40) SORT1NPC1RAB9AGAAKDM4E
Benzene SCHEMBL4261158 0.76 SORT1 (0.55) SORT1NPC1RAB9AGAAKDM4E
SCHEMBL330472 0.74 KMT2A (0.61) NPC1RAB9AGAAHTTALDH1A1
SCHEMBL4757488 0.73 SLC2A1 (0.41) SORT1NPC1RAB9AGAAKDM4E
SCHEMBL27582684 0.73 CSNK2A2 (0.56) SORT1NPC1RAB9AGAAKDM4E
SCHEMBL6153615 0.71 RAB9A (0.67) NPC1RAB9AGAAKDM4EHPGD
SCHEMBL330479 0.71 RAB9A (0.67) SORT1NPC1RAB9AGAAHTT
SCHEMBL4757021 0.71 SORT1 (0.46) SORT1NPC1RAB9AGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SORT1 4431/4885NPC1 585/4885RAB9A 1694/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC SORT1 4431/4885NPC1 585/4885RAB9A 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.